Fulgent Genetics Inc (FLGT) — Cash Flow-to-Debt Ratio
Fulgent Genetics Inc (FLGT) has a Cash Flow-to-Debt Ratio of -0.25x as of June 2026, meaning its operating cash flow of $-23.76 Million could theoretically repay 0% of its total liabilities ($93.24 Million) in one year. See FLGT financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Fulgent Genetics Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Fulgent Genetics Inc across 12 annual periods. For the full cash flow conversion analysis, see Fulgent Genetics Inc (FLGT) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Fulgent Genetics Inc (2014–2025)
Year-by-year debt coverage analysis for Fulgent Genetics Inc. Check FLGT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.95x | $-101.64 Million | $106.81 Million | ▼ -510.3% |
| 2024 | 0.23x | $21.06 Million | $90.81 Million | ▼ -12.4% |
| 2023 | 0.26x | $27.00 Million | $102.04 Million | ▼ -87.9% |
| 2022 | 2.18x | $253.52 Million | $116.18 Million | ▼ -54.3% |
| 2021 | 4.77x | $538.58 Million | $112.84 Million | ▲ +344.9% |
| 2020 | 1.07x | $140.63 Million | $131.07 Million | ▲ +16.3% |
| 2019 | 0.92x | $5.52 Million | $5.98 Million | ▲ +475.2% |
| 2018 | -0.25x | $-675.00K | $2.75 Million | ▼ -154.0% |
| 2017 | 0.46x | $1.33 Million | $2.92 Million | ▼ -63.2% |
| 2016 | 1.24x | $4.41 Million | $3.56 Million | ▲ +187.6% |
| 2015 | -1.41x | $-969.00K | $686.00K | ▲ +86.0% |
| 2014 | -10.08x | $-4.40 Million | $436.00K | — |